UroGen Pharma Ltd (URGN) — Net Asset Quality Index
UroGen Pharma Ltd (URGN) has a Net Asset Quality Index of -49.0% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $253.69 Million minus total liabilities of $377.94 Million yields net assets of $-124.25 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of UroGen Pharma Ltd to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
UroGen Pharma Ltd Net Asset Quality Index Over Time (2013–2025)
This chart shows how UroGen Pharma Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the index stands at -49.0%, representing net assets of $-124.25 Million against total assets of $253.69 Million USD. See UroGen Pharma Ltd current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for UroGen Pharma Ltd (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for UroGen Pharma Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see URGN market cap.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | -52.6% | $-105.47 Million | $200.46 Million | $305.93 Million | ▼ -49.5 pp |
| 2024 | -3.1% | $-8.80 Million | $285.71 Million | $294.51 Million | ▲ +33.5 pp |
| 2023 | -36.6% | $-65.21 Million | $178.31 Million | $243.52 Million | ▲ +29.3 pp |
| 2022 | -65.9% | $-89.36 Million | $135.62 Million | $224.98 Million | ▼ -72.9 pp |
| 2021 | 7.0% | $8.41 Million | $119.75 Million | $111.33 Million | ▼ -72.0 pp |
| 2020 | 79.0% | $96.36 Million | $122.00 Million | $25.65 Million | ▼ -10.1 pp |
| 2019 | 89.1% | $180.30 Million | $202.39 Million | $22.09 Million | ▲ +2.1 pp |
| 2018 | 87.0% | $90.09 Million | $103.56 Million | $13.46 Million | ▼ -3.7 pp |
| 2017 | 90.7% | $68.52 Million | $75.55 Million | $7.04 Million | ▲ +20.0 pp |
| 2016 | 70.7% | $16.31 Million | $23.06 Million | $6.75 Million | ▼ -17.7 pp |
| 2015 | 88.5% | $17.15 Million | $19.39 Million | $2.24 Million | ▲ +8.9 pp |
| 2014 | 79.6% | $3.47 Million | $4.36 Million | $891.00K | ▼ -5.4 pp |
| 2013 | 85.0% | $2.74 Million | $3.23 Million | $484.00K | — |